FDA Links Suicide And Epilepsy Drugs
The U.S. Food and Drug Administration is considering adding suicide warnings to a large class of blockbuster epilepsy drugs after a damaging agency report, regulators said in a meeting with industry...To view the full article, register now.
Already a subscriber? Click here to view full article